Syncom Formulations Shows Resilience Amid Market Sentiment Shift in Pharmaceuticals Sector
Syncom Formulations (India) Ltd, a small-cap pharmaceutical company, reached its upper circuit limit today, with a notable trading volume of approximately 7.58 lakh shares and a turnover of around Rs 1.38 crore. The stock's performance indicates a positive shift in market sentiment, outperforming its sector average.
Syncom Formulations (India) Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant activity today, hitting its upper circuit limit with a high price of Rs 18.86. The stock experienced a positive change of Rs 0.28, translating to a percentage increase of 1.56%. Throughout the trading session, Syncom Formulations recorded a total traded volume of approximately 7.58 lakh shares, resulting in a turnover of around Rs 1.38 crore. The last traded price stood at Rs 18.25, indicating a notable performance compared to the sector's average return of 0.48% and the Sensex's return of 0.41%.
Despite a recent trend reversal after three consecutive days of decline, the stock has managed to outperform its sector by 1.79%. While the stock's moving averages indicate it is performing better than the 5-day and 100-day averages, it remains below the 20-day, 50-day, and 200-day averages.
Overall, Syncom Formulations has demonstrated resilience in today's trading, reflecting a positive shift in market sentiment.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
